Trebananib (AMG 386) in Combination With Sunitinib in Patients With Metastatic Renal Cell Cancer: An Open-Label, Multicenter, Phase II Study.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Dror Michaelson Toni K Choueiri Tomasz Demkow Alain Ravaud |
| Publication date | August 24, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |